LIU Si-yang, WU Yi-long. Ongoing Clinical Trials of PD-1 and PD-L1 Inhibitors for Lung Cancer in China[J]. Journal of Evidence-Based Medicine, 2017, 17(5): 259-259. DOI: 10.12019/j.issn.1671-5144.2017.05.002
|
Citation:
|
LIU Si-yang, WU Yi-long. Ongoing Clinical Trials of PD-1 and PD-L1 Inhibitors for Lung Cancer in China[J]. Journal of Evidence-Based Medicine, 2017, 17(5): 259-259. DOI: 10.12019/j.issn.1671-5144.2017.05.002
|
LIU Si-yang, WU Yi-long. Ongoing Clinical Trials of PD-1 and PD-L1 Inhibitors for Lung Cancer in China[J]. Journal of Evidence-Based Medicine, 2017, 17(5): 259-259. DOI: 10.12019/j.issn.1671-5144.2017.05.002
|
Citation:
|
LIU Si-yang, WU Yi-long. Ongoing Clinical Trials of PD-1 and PD-L1 Inhibitors for Lung Cancer in China[J]. Journal of Evidence-Based Medicine, 2017, 17(5): 259-259. DOI: 10.12019/j.issn.1671-5144.2017.05.002
|
DownLoad: